Literature DB >> 19367122

Ginger-derived phenolic substances with cancer preventive and therapeutic potential.

Joydeb Kumar Kundu, Hye-Kyung Na, Young-Joon Surh.   

Abstract

Ginger, the rhizomes of Zingiber officinale Roscoe (Zingiberaceae), has widely been used as a spice and condiment in different societies. Besides its food-additive functions, ginger has a long history of medicinal use for the treatment of a variety of human ailments including common colds, fever, rheumatic disorders, gastrointestinal complications, motion sickness, diabetes, cancer, etc. Ginger contains several nonvolatile pungent principles viz. gingerols, shogaols, paradols and zingerone, which account for many of its health beneficial effects. Studies conducted in cultured cells as well as in experimental animals revealed that these pungent phenolics possess anticarcinogenic properties. This chapter summarizes updated information on chemopreventive and chemotherapeutic effects of ginger-derived phenolic substances and their underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367122     DOI: 10.1159/000212750

Source DB:  PubMed          Journal:  Forum Nutr        ISSN: 0067-8198


  28 in total

Review 1.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

2.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

3.  Evaluation of antimutagenic and protective effects of Parkinsonia aculeata L. leaves against H2O2 induced damage in pBR322 DNA.

Authors:  Sonia Sharma; Sushant Sharma; Adarsh Pal Vig
Journal:  Physiol Mol Biol Plants       Date:  2016-02-22

4.  Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.

Authors:  Hideaki Kabuto; Tomoko T Yamanushi
Journal:  Neurochem Res       Date:  2011-07-19       Impact factor: 3.996

5.  Ginger.

Authors:  Julie L Ryan; Gary R Morrow
Journal:  Oncol Nurse Ed       Date:  2010-02-16

6.  [6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2.

Authors:  Myoung Ok Kim; Mee-Hyun Lee; Naomi Oi; Sung-Hyun Kim; Ki Beom Bae; Zunnan Huang; Dong Joon Kim; Kanamata Reddy; Sung-Young Lee; Si Jun Park; Jae Young Kim; Hua Xie; Joydeb Kumar Kundu; Zae Young Ryoo; Ann M Bode; Young-Joon Surh; Zigang Dong
Journal:  Carcinogenesis       Date:  2013-11-26       Impact factor: 4.944

7.  Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract.

Authors:  Sushma R Gundala; Rao Mukkavilli; Chunhua Yang; Pooja Yadav; Vibha Tandon; Subrahmanyam Vangala; Satya Prakash; Ritu Aneja
Journal:  Carcinogenesis       Date:  2014-01-15       Impact factor: 4.944

8.  Ginger phytochemicals exhibit synergy to inhibit prostate cancer cell proliferation.

Authors:  Meera Brahmbhatt; Sushma R Gundala; Ghazia Asif; Shahab A Shamsi; Ritu Aneja
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

9.  Identification of Michael acceptor-centric pharmacophores with substituents that yield strong thioredoxin reductase inhibitory character correlated to antiproliferative activity.

Authors:  Fei-Fei Gan; Kamila K Kaminska; Hong Yang; Chin-Yee Liew; Pay-Chin Leow; Choon-Leng So; Lan N L Tu; Amrita Roy; Chun-Wei Yap; Tse-Siang Kang; Wai-Keung Chui; Eng-Hui Chew
Journal:  Antioxid Redox Signal       Date:  2013-02-28       Impact factor: 8.401

10.  Identification of a Dual Inhibitor of Janus Kinase 2 (JAK2) and p70 Ribosomal S6 Kinase1 (S6K1) Pathways.

Authors:  Sanguine Byun; Semi Lim; Ji Young Mun; Ki Hyun Kim; Timothy R Ramadhar; Lee Farrand; Seung Ho Shin; N R Thimmegowda; Hyong Joo Lee; David A Frank; Jon Clardy; Sam W Lee; Ki Won Lee
Journal:  J Biol Chem       Date:  2015-08-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.